Kayo Nagashima
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kayo Nagashima.
Biochemical and Biophysical Research Communications | 2003
Mikio Yanase; Hitoshi Ikeda; Itsuro Ogata; Atsushi Matsui; Eisei Noiri; Tomoaki Tomiya; Masahiro Arai; Yukiko Inoue; Kazuaki Tejima; Kayo Nagashima; Takako Nishikawa; Masao Shibata; Mitsuo Ikebe; Marcos Rojkind; Kenji Fujiwara
Using a rat myofibroblast-like hepatic stellate cell line, we studied the actomyosin-based cytoskeletal actions mediated by Rho-kinase and/or myosin light chain kinase (MLCK). Calmodulin/MLCK inhibitors W-7 and ML-7 attenuated cell migration dose-relatedly at concentrations from 10(-6) to 10(-4)M and collagen gel-contraction by the cells at 10(-4)M, respectively. Rho-kinase inhibitors Y-27632 and HA1077 attenuated the gel-contraction at concentrations from 10(-6) to 10(-4) M, respectively. These Rho-kinase inhibitors attenuated cell migration at 10(-7)M but enhanced the migration at 10(-4)M, respectively. They altered cell morphology showing prominent peripheral actin bundles and sparse central stress fibers, in comparison with the calmodulin/MLCK inhibitors. Both ML-7 and Y-27632 attenuated phosphorylation of myosin regulatory light chain and cell attachment to extracellular substrate. ML-7 attenuated the activation of GTP-binding protein Rac, while Y-27632 did not. These findings suggest that the actomyosin-based cytoskeletal actions can be functionally diverse depending on the Rho-kinase-mediated pathway and the MLCK-mediated pathway.
Biochemical and Biophysical Research Communications | 2002
Tomoaki Tomiya; Yukiko Inoue; Mikio Yanase; Masahiro Arai; Hitoshi Ikeda; Kazuaki Tejima; Kayo Nagashima; Takako Nishikawa; Kenji Fujiwara
Branched-chain amino acids (BCAAs) modulate various cellular functions, in addition to providing substrates for the production of proteins. In this study, we examined the effect of BCAAs on the secretion of hepatocyte growth factor (HGF) by hepatic stellate cells. A hepatic stellate cell clone was cultured in medium supplemented with various concentrations of valine, leucine, or isoleucine. Of these BCAAs, leucine markedly induced an increase in the levels of HGF in the medium in a dose-dependent manner. The addition of valine or isoleucine had no significant effect on HGF levels in the medium. The difference in levels of HGF in the medium between leucine-treated and non-treated cells was enhanced by the incubation period. These results demonstrate that, among BCAAs, leucine stimulates the secretion of HGF by cultured hepatic stellate cells.
Journal of Gastroenterology and Hepatology | 2007
Masahiro Arai; Kazuaki Tejima; Hitoshi Ikeda; Tomoaki Tomiya; Mikio Yanase; Yukiko Inoue; Kayo Nagashima; Takako Nishikawa; Naoko Watanabe; Masao Omata; Kenji Fujiwara
Brief periods of tissue ischemia produced tissue resistance to prolonged ischemia and reperfusion, a phenomenon called ischemic preconditioning. The mechanisms of ischemic preconditioning were examined in a rat warm ischemia–reperfusion model as well as the effect of ischemic preconditioning on liver regeneration. Ischemic preconditioning decreased liver injury after warm ischemia–reperfusion, which was reversed by Kupffer cell depletion. Ischemic preconditioning stimulated Kupffer cells to produce reactive oxygen species. Scavengers of reactive oxygen species reversed the effect of ischemic preconditioning, and pretreatment with sublethal dose of hydrogen peroxide mimicked ischemic preconditioning effect. Rat livers were preconditioned by ischemia and subjected to 70% partial hepatectomy. Liver regeneration was then evaluated serially. Ischemic preconditioning promoted liver regeneration, which was reversed by adenosine A2 receptor antagonism and mimicked by adenosine A2 receptor agonism. Promotion of liver regeneration by ischemic preconditioning and adenosine A2 receptor agonism were reversed by Kupffer cell depletion. In conclusion, ischemic preconditioning stimulates Kupffer cells to produce reactive oxygen species, leading to hepatocyte protection against warm ischemia–reperfusion injury; and ischemic preconditioning promoted liver regeneration via adenosine A2 receptor pathway in Kupffer cells.
Chemotherapy | 2007
Tomoaki Tomiya; Miho Yamaoka; Yukiko Inoue; Takako Nishikawa; Mikio Yanase; Hitoshi Ikeda; Kazuaki Tejima; Kayo Nagashima; Naoko Watanabe; Masao Omata; Kenji Fujiwara
Background: Rapamycin is a specific inhibitor of the mammalian target of rapamycin (mTOR). The effect of rapamycin on proliferation and cellular function was studied in hepatocytes stimulated by hepatocyte growth factor (HGF) or transforming growth factor-α (TGFα). Methods and Results: When isolated rat hepatocytes were cultured at low density, the addition of HGF or TGFα increased DNA synthesis but did not affect albumin or fibrinogen concentrations in the medium. In contrast, in hepatocytes cultured at high density, the albumin and fibrinogen concentrations, but not DNA synthesis, were increased by HGF or TGFα. The HGF- or TGFα-induced increase in DNA synthesis and in albumin or fibrinogen concentrations was suppressed by the addition of rapamycin, as well as wortmannin, a phosphatidylinositol-3 kinase inhibitor. Conclusion: HGF and TGFα stimulate proliferation and function of hepatocytes depending upon the conditions, and rapamycin inhibited these stimulatory effects, possibly by inhibiting the mTOR-dependent signaling pathway.
Comparative Hepatology | 2004
Mikio Yanase; Hitoshi Ikeda; Atsushi Matsui; Eisei Noiri; Tomoaki Tomiya; Masahiro Arai; Yukiko Inoue; Kazuaki Tejima; Kayo Nagashima; Takako Nishikawa; Satoshi Kimura; Kenji Fujiwara; Marcos Rojkind; Itsuro Ogata
Department of Internal Medicine, Kawakita General Hospital, Tokyo, JapanEmail: Mikio Yanase* - [email protected]; Hitoshi Ikeda- [email protected]; Atsushi Matsui - [email protected]; Eisei Noiri - [email protected]; Tomoaki Tomiya [email protected]; Masahiro Arai - [email protected]; Yukiko Inoue - [email protected]; Kazuaki Tejima - yanase-1I [email protected]; Kayo Nagashima- [email protected]; Takako Nishikawa - [email protected]; Satoshi Kimura - [email protected]; Kenji Fujiwara - [email protected]; Marcos Rojkind - [email protected]; Itsuro Ogata - [email protected]* Corresponding author
Gastroenterology | 2003
Hitoshi Ikeda; Hiroaki Satoh; Mikio Yanase; Yukiko Inoue; Tomoaki Tomiya; Masahiro Arai; Kazuaki Tejima; Kayo Nagashima; Hisato Maekawa; Naohisa Yahagi; Yutaka Yatomi; Soutaro Sakurada; Yoh Takuwa; Itsuro Ogata; Satoshi Kimura; Kenji Fujiwara
American Journal of Physiology-gastrointestinal and Liver Physiology | 2003
Hitoshi Ikeda; Kayo Nagashima; Mikio Yanase; Tomoaki Tomiya; Masahiro Arai; Yukiko Inoue; Kazuaki Tejima; Takako Nishikawa; Masao Omata; Satoshi Kimura; Kenji Fujiwara
Gastroenterology | 2004
Kazuaki Tejima; Masahiro Arai; Hitoshi Ikeda; Tomoaki Tomiya; Mikio Yanase; Yukiko Inoue; Kayo Nagashima; Takako Nishikawa; Naoko Watanabe; Masao Omata; Kenji Fujiwara
Biochemical and Biophysical Research Communications | 2004
Hitoshi Ikeda; Kayo Nagashima; Mikio Yanase; Tomoaki Tomiya; Masahiro Arai; Yukiko Inoue; Kazuaki Tejima; Takako Nishikawa; Naoko Watanabe; Masao Omata; Kenji Fujiwara
Life Sciences | 2006
Hitoshi Ikeda; Kayo Nagashima; Mikio Yanase; Tomoaki Tomiya; Masahiro Arai; Yukiko Inoue; Kazuaki Tejima; Takako Nishikawa; Naoko Watanabe; Kazuya Kitamura; Tomomi Isono; Naohisa Yahagi; Eisei Noiri; Mie Inao; Satoshi Mochida; Yukio Kume; Yutaka Yatomi; Kazuhiko Nakahara; Masao Omata; Kenji Fujiwara